Globus Medical GMED Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's stock-based comp?
- Globus Medical (GMED) reported stock-based comp of $12.62M in Q1 2026.
- How has Globus Medical's stock-based comp changed year-over-year?
- Globus Medical's stock-based comp decreased by 4.5% year-over-year, from $13.21M to $12.62M.
- What is the long-term trend for Globus Medical's stock-based comp?
- Over 4 years (2021 to 2025), Globus Medical's stock-based comp has grown at a 12.9% compound annual growth rate (CAGR), from $30.59M to $49.78M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock.
- How do you interpret stock-based comp?
- High levels indicate significant dilution potential for shareholders, though it helps preserve cash for operations.
- How does stock-based comp compare across companies?
- Standard across high-growth sectors; investors monitor this to assess dilution and alignment of management incentives.